Loading company…
Render Biotech develops products for hemostasis, point-of-care testing, and microbiology.
Founded in Shenzhen in 2010, Render Biotech develops healthcare products for hemostasis, point-of-care testing, and microbiology for use in hospitals, clinics, and laboratories. In July 2021, it raised USD 15.00 mn in Series A funding led by Qiming Venture Partners, with participation from Sequoia Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in